AWARDDELIVERY ORDEROther than small business
Delivery order 75N91019F00130FUNDACION INCIENSA
Overview
Award facts
- Net obligations
- $869.29K
- $869,287of $869.29K potential value
- Outlays (paid to date)
- $578.36K
- $578.36K paid of $869.29K obligated$578,360
- Period of performance
- Sep 16, 2019 to Sep 15, 2023
- Ended
- Modifications
- 3
- Latest action Sep 2, 2022
- Contract type
- Delivery order
- PIID 75N91019F00130
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
FOLLOW-UP OF PARTICIPANTS ENROLLED IN THE PRIMAVERA-ESCUDDO TRIAL
Dates and value
- Award date
- Signed on Sep 16, 2019
- Potential end of performance
- Sep 14, 2023
- Current value
- $869,287Base and exercised options
- Potential value (if all options are exercised)
- $869,287
- Parent contract vehicle
- HHSN261201700012I (IDC, single award) — 8 orders recorded under it
Obligations by fiscal year of action
- FY2022: $238,965
- FY2021: $295,832
- FY2020: $261,393
- FY2019: $73,097
Total across 4 fiscal years: $869,287
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 2, 2022. View on USAspending · Recipient on SAM.gov
Recipient
LocationSAN JOSE, CRI
UEIKDL2VERNRKA5
CAGE codeSFF99
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeInternational org
Parent companyFUNDACION INCIENSA
Business types and certifications
Nonprofit organizationInternational organization
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NIH NCI
- Funded from
- National cancer institute (0849)Program activities075-0849Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Costa Rica
Classification and competition
Classification
- Product or service (PSC)
- Q301MEDICAL- LABORATORY TESTING (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Sealed bidSB
- Set-aside
- Not reported
- Contract pricing
- Firm fixed priceJ
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Evauation of single dose protection afforded by the prophylactic hpv vaccines
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 16, 2019Base obligation at award: $73,097
- Latest action
- Sep 2, 2022 — Option exercisedModification P00003; obligation change +$238,965
- Latest substantive action
- Sep 2, 2022 — Option exercisedModification P00003; obligation change +$238,965
- Actions by type
- Base award1
- Option exercised2
- Change order1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $238,965
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- Foreign-owned business not incorporated in the U.S.D
- Country of product or service origin
- Costa ricaCRI
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- IDCB
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- National Institutes Of Health7529
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N910
- Transactions recorded under this award key
- 4
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N910
- Treasury accounts
- 075-2020/2020-0849-000
- 075-2021/2021-0849-000
- 075-2022/2022-0849-000
- 075-2025/2025-0849-000
- 075-X-0849-000
- Object classes
- 25.1: Advisory and assistance services
- 25.2: Other services from non-Federal sources
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression